Creative Medical Tech Files 8-K on Shareholder Votes & Financials
Ticker: CELZ · Form: 8-K · Filed: Jul 25, 2024 · CIK: 1187953
| Field | Detail |
|---|---|
| Company | Creative Medical Technology Holdings, INC. (CELZ) |
| Form Type | 8-K |
| Filed Date | Jul 25, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financials, filing
Related Tickers: CMED
TL;DR
CMED filed an 8-K for shareholder votes and financials as of 7/19.
AI Summary
Creative Medical Technology Holdings, Inc. filed an 8-K on July 25, 2024, reporting on matters submitted to a vote of security holders and financial statements as of July 19, 2024. The company, formerly known as Jolley Marketing Inc., is incorporated in Nevada and operates in the biological products sector.
Why It Matters
This filing provides updates on important corporate actions and financial status, which are crucial for investors to assess the company's current standing and future direction.
Risk Assessment
Risk Level: low — This is a routine filing of corporate information and does not inherently indicate new risks.
Key Players & Entities
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (company) — Registrant
- JOLLEY MARKETING INC (company) — Former company name
- July 19, 2024 (date) — Date of earliest event reported
- July 25, 2024 (date) — Filing date
- Nevada (jurisdiction) — State of incorporation
- 211 E Osborn Road, Phoenix, AZ 85012 (address) — Principal executive offices
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
What is the exact date of the earliest event reported in this 8-K?
The earliest event reported is dated July 19, 2024.
When was this Form 8-K filed with the SEC?
This Form 8-K was filed on July 25, 2024.
What was the previous name of Creative Medical Technology Holdings, Inc.?
The company was formerly known as JOLLEY MARKETING INC.
What is the principal executive office address for the company?
The principal executive offices are located at 211 E Osborn Road, Phoenix, AZ 85012.
Filing Stats: 658 words · 3 min read · ~2 pages · Grade level 12.3 · Accepted 2024-07-25 16:10:25
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share CELZ The Nasdaq Stock Mar
Filing Documents
- celz_8k.htm (8-K) — 38KB
- 0001477932-24-004377.txt ( ) — 157KB
- celz-20240719.xsd (EX-101.SCH) — 6KB
- celz-20240719_lab.xml (EX-101.LAB) — 14KB
- celz-20240719_cal.xml (EX-101.CAL) — 1KB
- celz-20240719_pre.xml (EX-101.PRE) — 9KB
- celz-20240719_def.xml (EX-101.DEF) — 2KB
- celz_8k_htm.xml (XML) — 4KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On July 19, 2024, Creative Medical Technology Holdings, Inc. (the "Company") held its 2024 Annual Meeting of Stockholders (the "Annual Meeting") to consider and vote on proposals for (i) the election of the director nominees named in the definitive proxy statement (the "Proxy Statement") for the Annual Meeting filed with the Securities and Exchange Commission on June 5, 2024 ("Proposal I"); (ii) the approval of the compensation of the Company's named executive officers ("Proposal II"); and (iii) the ratification of the appointment of Haynie & Company to serve as the Company's independent registered public accountants ("Proposal III"). Each of the foregoing proposals is described in more detail in the Proxy Statement. Stockholders holding an aggregate of 832,170 shares of common stock, representing 61.7% of the outstanding shares of the Company's common stock as of the record date, and which constituted a quorum, were present in person or represented by proxy at the Annual Meeting. The proposal described in the Proxy Statement to increase the authorized shares of common stock of the Company was withdrawn by management prior to the Annual Meeting and was not voted on. The results of the voting at the Annual Meeting are presented below. Proposal I - The five director nominees were all elected to the Board as follows: Director For Withhold Timothy Warbington 312,403 147,859 Donald Dickerson 338,694 121,568 Michael H. Finger 337,737 122,525 Susan Snow 311,531 148,731 Bruce S. Urdang, Esq. 337,685 122,577 Proposal II - The compensation of the Company's named executive officers was approved as follows: For Against Abstain Broker Non-Votes 217,019 227,926 15,317 371,908 Proposal III –The ratification of the appointment of Haynie & Company was approved as follows: For Against Abstain Broker Non-Votes 684,717 90,973 56,480 N/A
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Creative Medical Technology Holdings, Inc. Date: July 25, 2024 By: /s/ Timothy Warbington Timothy Warbington, Chief Executive Officer 3